cngrc peptide-tnf alpha conjugate
Recombinant proteinexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2004 (NCT00098943)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Aminopeptidase NINHIBITOR
ANPEP inhibitor
Chemistry & pharmacology
- Multi-specific
- No
- Payload
- TNFA
Oral
No
Parenteral
No
Topical
No
Also known as
- cngrc peptide-tnf alpha conjugate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00098943 | Phase 1 | Sep 1, 2004 | European Organisation for Research and Treatment of Cancer, Radboud University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| European Organisation for Research and Treatment of Cancer | Academic/Hospital | 1 | 1 | 1 | 2004 |
| Radboud University | Academic/Hospital | 1 | 0 | 1 | 2004 |
2 organizations
Page 1 / 1